Cybin: Top Value Psychedelic Stock

Group 1 - The psychedelic medicine sector presents unique value investment opportunities, characterized as a biotech sector that is still in its early stages but has reached advanced clinical trials and gained institutional support [1] - The sector offers substantial room for growth, indicating potential for significant returns on investment as it matures [1]